The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 09, 2021

Filed:

Sep. 22, 2017
Applicant:

Regeneron Pharmaceuticals, Inc., Tarrytown, NY (US);

Inventors:

Lauric Haber, Rye Brook, NY (US);

Eric Smith, New York, NY (US);

Marcus Kelly, New York, NY (US);

Jessica R. Kirshner, New York, NY (US);

Sandra Coetzee, White Plains, NY (US);

Alison Crawford, Dobbs Ferry, NY (US);

Thomas Nittoli, Pearl River, NY (US);

Yashu Liu, Tarrytown, NY (US);

Assignee:

Regeneron Pharmaceuticals, Inc., Tarrytown, NY (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C07K 16/30 (2006.01); C07K 16/28 (2006.01); C07K 16/46 (2006.01); A61K 39/395 (2006.01); C07K 16/44 (2006.01); A61K 47/68 (2017.01); G01N 33/574 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
C07K 16/3092 (2013.01); A61K 39/395 (2013.01); A61K 39/39558 (2013.01); A61K 47/6849 (2017.08); A61K 47/6851 (2017.08); A61K 47/6869 (2017.08); C07K 16/2809 (2013.01); C07K 16/2863 (2013.01); C07K 16/3069 (2013.01); C07K 16/44 (2013.01); C07K 16/468 (2013.01); G01N 33/57492 (2013.01); A61K 2039/505 (2013.01); C07K 2317/24 (2013.01); C07K 2317/31 (2013.01); C07K 2317/33 (2013.01); C07K 2317/51 (2013.01); C07K 2317/515 (2013.01); C07K 2317/56 (2013.01); C07K 2317/565 (2013.01); C07K 2317/73 (2013.01); C07K 2317/92 (2013.01); C07K 2317/94 (2013.01); G01N 2333/705 (2013.01);
Abstract

Mucin 16 (MUC16) is highly expressed in ovarian cancer and expression on cancer cells is shown to protect tumor cells from the immune system. The present invention provides novel full-length human IgG antibodies that bind to human MUC16 (monospecific antibodies) and antigen-binding fragments thereof. In some embodiments, the anti-MUC16 antibodies and the antigen-binding fragments thereof are useful in diagnostic methods for identifying the presence of MUC16 in tissue and/or plasma samples.


Find Patent Forward Citations

Loading…